Pascal Soriot

Pascal Soriot
Born Pascal Claude Roland Soriot
(1959-05-23) 23 May 1959[1]
Nationality French
Alma mater École nationale vétérinaire d'Alfort[1] and HEC Paris
Occupation Businessman
Years active 1982–present
Salary GBP £3,507,000 (total compensation) [2]
Title CEO, AstraZeneca
Term 2012–2017
Successor Incumbent
Children 2

Pascal Claude Roland Soriot (born 23 May 1959) is the chief executive officer of the Anglo-Swedish pharmaceutical multinational company AstraZeneca, since October 2012.[2]

In July 2017, it was reported that Soriot would become the next CEO of Israel-based Teva Pharmaceutical Industries, succeeding Erez Vigodman,[3][4] though this was soon refuted.[5]

Early life

He studied veterinary medicine at university (École nationale vétérinaire d'Alfort at Maisons-Alfort in south-east Paris).[1] He later obtained an MBA at HEC Paris.[2]

Career

Roussel Uclaf

In April 1986, he joined Roussel Uclaf (formerly France's second largest pharmaceutical company, until bought by Hoechst AG in 1997)[6] as a salesman, where he lived in Australia.[1] In 1996 he became General Manager of Hoechst Marion Roussel in Australia, moving to Tokyo in April 1997

Aventis

In 2000 he moved to Aventis in America, becoming chief operating officer of Aventis USA in 2002, which became Sanofi Aventis USA in 2004.

Roche

He joined Roche in 2006. From April 2009 to 2010 he was chief executive of the Roche subsidiary Genentech. He rejoined Roche Pharma AG in 2010 as chief operating officer.[7]

AstraZeneca

In August 2012 he was named as the new chief executive of AstraZeneca,[8] the world's fifth largest pharmaceutical company, when aged 53. He took up the post on 1 October 2012.

Personal life

He is married and has two children.[9]

References

  1. 1 2 3 4 "ascal Soriot: Leader of the great escape". Ft.com. Retrieved 26 January 2017.
  2. 1 2 3 "Executive Profile: Pascal Soriot". Bloomberg. Retrieved 3 April 2015.
  3. ↑ Reuters Editorial (14 May 2014). "AstraZeneca's CEO Soriot to join Israeli drugs company Teva: report". Reuters. Retrieved 12 July 2017.
  4. ↑ "Israeli newspaper reports that AstraZeneca CEO Pascal Soriot has agreed to take the helm at Teva – ENDPOINTS NEWS". Endpts.com. Retrieved 12 July 2017.
  5. ↑ "Pascal Soriot looks set to stay as AstraZeneca chief".
  6. ↑ "Pascal Soriot". Roche.com. Retrieved 26 January 2017.
  7. ↑ "AstraZeneca Names Roche's Pascal Soriot as CEO". Bloomberg. Retrieved 6 February 2013.
  8. ↑ Rowley, Emma. "AstraZeneca appoints Roche's Pascal Soriot as new chief". Telegraph. Retrieved 26 January 2017.
  9. ↑ James Ashton (16 May 2014). "Astrazeneca chief Pascal Soriot: I can carry on curing the company, says scientist in £63bn bid battle". Standard.co.uk. Retrieved 26 January 2017.
Business positions
Preceded by
David Brennan		 Chief Executive of AstraZeneca
2012 –		 Succeeded by
Incumbent
Preceded by
 Chief Operating Officer of Hoffmann-La Roche
2010 – 2012		 Succeeded by
Daniel O'Day
Preceded by
 Chief Executive of Genentech
2009 – 2010		 Succeeded by
Ian Clark
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.